CytomX Therapeutics, Inc. - Filer Information

Symbol
CTMX on Nasdaq
Entity
Company
CIK
0001501989
EIN
273521219
Business address
151 Oyster Point Blvd., Suite 400, South San Francisco, CA, 94080
Phone
650.515.3185
State of incorporation
DE
Fiscal year end
December 31
Category
Accelerated filer
Smaller reporting company
All SEC filings
View on sec.gov
Get insider transactions for this issuer
Get financial reports for this company